Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer’s Biomarkers in Daily Practice (ABIDE) Project

IMPORTANCE: Biomarkers do not determine conversion to Alzheimer disease (AD) perfectly, and criteria do not specify how to take patient characteristics into account. Consequently, biomarker use may be challenging for clinicians, especially in patients with mild cognitive impairment (MCI). OBJECTIVE:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Neurol
Main Authors: van Maurik, Ingrid S., Zwan, Marissa D., Tijms, Betty M., Bouwman, Femke H., Teunissen, Charlotte E., Scheltens, Philip, Wattjes, Mike P., Barkhof, Frederik, Berkhof, Johannes, van der Flier, Wiesje M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5822193/
https://ncbi.nlm.nih.gov/pubmed/29049480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2017.2712
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados